Sevenum, the Netherlands, 13 November 2021. It's a historic day: Last Friday, SHOP APOTHEKE EUROPE exceeded the billion euro turnover mark for the first time. The online pharmacy, which had gone public in autumn 2016, started trading in the year of its IPO with annual sales of EUR 177.4 million. In the current fiscal year, SHOP APOTHEKE EUROPE's Management Board expects sales of over one billion euros - equivalent to a six-fold increase in business volume since the year of its IPO.

Stefan Feltens, CEO of SHOP APOTHEKE EUROPE: "The Corona pandemic has significantly accelerated the shift of retail towards e-commerce, and online sales of prescription medicines will gain further importance with the introduction of electronic prescriptions in Germany in 2022. Our growth story is far from over."

With its presence in seven European markets, SHOP APOTHEKE EUROPE is well-positioned to benefit from the growing online penetration of the sector. The company started its evolution from a pure online pharmacy to a customer-centric e-pharmacy platform in 2019. SHOP APOTHEKE EUROPE now offers in cooperation with partners same-day delivery of medicines in Germany's metropolitan regions as well as online doctor services. The company will also significantly expand its offering as a platform for medicine-related products with the expansion of its digital marketplace in the coming months. Service offerings such as digital medication management for chronically ill patients round off SHOP APOTHEKE EUROPE's portfolio.

ABOUT SHOP APOTHEKE EUROPE.

SHOP APOTHEKE EUROPE is a leading and fast-growing online pharmacy in Europe, currently operating in Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland.

Headquartered in the Dutch logistics centre of Sevenum near Venlo with locations in Cologne, Berlin, Munich, Tongeren, Warsaw, Milan, Lille and Eindhoven, SHOP APOTHEKE EUROPE offers its customers a broad range of more than 100,000 original products at attractive prices: OTC, beauty and personal care products as well as prescription drugs, supplemented by high quality natural food and health products, low carb products and sports nutrition. Currently, more than 7 million active customers trust SHOP APOTHEKE EUROPE.

Since safe and reliable pharmaceutical advice are top priorities at SHOP APOTHEKE EUROPE, the e-pharmacy provides comprehensive pharmaceutical consulting services.

In preparation for the expected introduction of electronic prescriptions in Germany, the company will further improve the customer experience with focus on disease-specific digital medication management services following the acquisition of SMARTPATIENT in January 2021. This is a key part of SHOP APOTHEKE EUROPE's strategy to transform itself from a pure online retailer into a truly customer-centric e-pharmacy platform.

SHOP APOTHEKE EUROPE N.V. has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) since 2016 and has been part of the MDAX stock index since September 2020.
 
PRESS CONTACTS.

Trade and popular media:
Sven Schirmer
Tel: +49 221 99 53 44 31
Email: presse@shop-apotheke.com

Financial media:
Bettina Fries
Tel: +49 211 75 80 779
Email: presse@shop-apotheke.com

Investor relations:
Carmen Herkenrath
Tel.: +31 77 850 6109
Email: carmen.herkenrath@shop-apotheke.com

Thomas Schnorrenberg
Mobile: +49 151 465 31317
Email: presse@shop-apotheke.com